Epistaxis Market – Novel Hemostatic Agents

a adăugat un sunet Health

2026-09-11 09:56:40 -

Market Overview The epistaxis market is being driven by novel hemostatic agents that improve clot formation and reduce bleeding. These agents include topical tranexamic acid, chitosan-based dressings, and thrombin-based products. The market is projected to grow through 2030, driven by growing demand and technological advances. Emergency departments and ENT clinics are increasingly adopting...

0 Commentarii 0 Distribuiri 46 Views 0 previzualizare